The global Blood Collection Market was valued at USD 5.0 billion in 2025 and is projected to grow from USD 5.3 billion in 2026 to USD 8.2 billion by 2033, registering a CAGR of 6.3% from 2026 to 2033. The market continues to expand due to the rising volume of diagnostic procedures, increasing prevalence of chronic and infectious diseases, and growing demand for accurate laboratory...

As 2026 commences, global health authorities are enforcing a transition from siloed electronic records to a unified longitudinal patient view. This evolution is driven by the recent World Health Assembly resolution aimed at eliminating data fragmentation that currently hinders emergency response and chronic care management. With the integration of advanced semantic layers, clinicians in major...

7 federal mandates forcing seamless clinical data exchange in 2026 As we enter the second quarter of 2026, the global push for unified patient records has reached a critical tipping point, driven by the rollout of the Trusted Exchange Framework and Common Agreement (TEFCA) version 3.0. Healthcare systems across North America and the European Union are now under strict enforcement to eliminate...

According to the latest report published by Data Bridge Market Research, the Phytonutrient Ingredients in Food Market  CAGR Value The global phytonutrient ingredients in food market size was valued at USD 5.01 billion in 2025 and is expected to reach USD 8.55 billion by 2033, at a CAGR of 6.90% during the forecast period With the effectual use of technology, innovative...

Anti-Fingerprint Coatings Market Summary: According to the latest report published by Data Bridge Market Research, the  Anti-Fingerprint Coatings Market CAGR Value The global Anti-Fingerprint Coatings Market size was valued at USD 888.31 million in 2025 and is expected to reach USD 1363.28 million by 2033, at a CAGR of 5.50% during the forecast period. The idea of this...

7 federal approvals for vascularized 3D bioprinted tissues in early 2026 As 2026 begins, the global regenerative medicine landscape is pivoting toward full-scale clinical integration, driven by new FDA and EMA frameworks for bio-ink standardization. Healthcare systems in North America and Western Europe are now moving past simple scaffold structures to functional, vascularized tissue...